Indeed, treatment of IL-9 knockout mice with hyperIL-6 abrogated the protective effects of IL-9 deficiency and led to a marked tumour growth, thereby demonstrating that IL-9 is an important regulator of IL-6 trans-signalling effects in colorectal neoplasias. This evidence concerns the gene IL6 and neoplasm.